HEALTHADD
DSP Nifty Healthcare ETF
Each stock's 10,000-path forecast, rendered as light.
DSP Nifty Healthcare ETF (HEALTHADD) Stock Analysis & Case Study
Is HEALTHADD a good buy? The data-driven verdict.
on the numbers it worth a closer look, a Downstox Snapshot Score of 61/100.
On the numbers, DSP Nifty Healthcare ETF (HEALTHADD) worth a closer look, a Downstox Snapshot Score of 61/100, weighing a 76% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
How HEALTHADD ranks against the 2,373 companies in our screener
HEALTHADD is not currently one of the 2,373 companies in our live screener universe, so no percentile comparison is available for it here.
HEALTHADD share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 1.4y of HEALTHADD history (18%/yr drift, 15%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| HEALTHADD 2027 | ₹16 | ₹19 | ₹23 | +11% |
| HEALTHADD 2028 | ₹16 | ₹21 | ₹28 | +24% |
| HEALTHADD 2029 | ₹17 | ₹23 | ₹33 | +38% |
| HEALTHADD 2030 | ₹18 | ₹26 | ₹38 | +54% |
| HEALTHADD 2031 | ₹19 | ₹29 | ₹45 | +72% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability HEALTHADD goes up, or doubles?
The bull case for HEALTHADD
- A 10,000-path probability model puts a 76% chance the price is higher in a year, with a median target of ₹19 (+11%).
- Relatively low volatility (15%/yr), a steadier ride than the typical mid/small-cap.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹33.
The bear case & risks
- No model or past record guarantees future returns, treat this as one input, not a decision.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹17.
HEALTHADD volatility & expected range, how bumpy is the ride?
Over the last 1.4 years HEALTHADD compounded at 18%/year with annualized volatility of 15%. That volatility implies a 1-year 80% range of ₹16-₹23, the honest backbone behind any single price target.
HEALTHADD price forecast, the full 60-month probability fan
HEALTHADD price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds HEALTHADD hits common targets within the simulated horizon?
Full multi-horizon detail on the HEALTHADD price target & forecast page.
HEALTHADD MTF margin & leverage across 4 brokers
Margin Trading Facility lets you buy HEALTHADD with part of the capital. Lower margin % = higher leverage. Rates compared across 4 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 26.50% | 3.8× |
| GrowwCHEAPEST | 26.50% | 3.8× |
| Dhan | 30.00% | 3.3× |
| Anand RathiCHEAPEST | 26.50% | 3.8× |
Compare every broker on the HEALTHADD MTF page.
About DSP Nifty Healthcare ETF: sector, index & market-cap context
DSP Nifty Healthcare ETF (HEALTHADD) is an NSE-listed company. See more stocks on our screener.
How the HEALTHADD Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of DSP Nifty Healthcare ETF's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
HEALTHADD analysis, FAQs
Is DSP Nifty Healthcare ETF (HEALTHADD) a good buy?
On the numbers, DSP Nifty Healthcare ETF (HEALTHADD) worth a closer look, a Downstox Snapshot Score of 61/100, weighing a 76% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is HEALTHADD overvalued or undervalued?
Valuation ratios for HEALTHADD are tracked live on Downstox.
What is the HEALTHADD share price target for 2031?
HEALTHADD's probability-weighted 2031 median target is ₹29, with an 80% range of ₹19-₹45 (10,000-path Monte-Carlo).
What is the probability HEALTHADD doubles in 5 years?
The modelled probability of HEALTHADD reaching ₹34 (2×) within 5 years is 32%.
What is the bull case for HEALTHADD?
A 10,000-path probability model puts a 76% chance the price is higher in a year, with a median target of ₹19 (+11%). Relatively low volatility (15%/yr), a steadier ride than the typical mid/small-cap.
What are the risks in HEALTHADD?
No model or past record guarantees future returns, treat this as one input, not a decision.